Orestrate

This classification denotes a therapeutic estrogen with the molecular formula C27H36O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G9VC23W7W0, chemically known as 1,3,5(10)-estratrien-3-ol, 17beta-(1-cyclohexenyloxy)-, propionate but generally known as orestrate, which bears US NIH Compound Identifier 167462. European Medicines Agency schedules Orestrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09459MIG. The term ORESTRATE is an International Non-Proprietary Name. ORESTRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule orestrate under HS 29372300 and SITC 54153. As of Q4 2014, ORESTRATE remains the US FDA Preferred Term for this commodity. Orestrate bears US NLM identifiers UMLS ID C2698657 and NCI Concept Code C76997. SMILES: O(C1C2(C(C3C(CC2)c2c(CC3)cc(OC(=O)CC)cc2)CC1)C)C1=CCCCC1.